Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 2
2006 2
2007 3
2008 7
2009 4
2010 3
2011 3
2012 8
2013 4
2014 4
2015 6
2016 6
2017 12
2018 3
2019 5
2020 4
2021 4
2022 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Chronic myeloid leukemia.
Hantschel O. Hantschel O. Hemasphere. 2019 Jun 30;3(Suppl):47. doi: 10.1097/HS9.0000000000000254. eCollection 2019 Jun. Hemasphere. 2019. PMID: 35309819 Free PMC article. No abstract available.
Bcr-Abl: one kinase, two isoforms, two diseases.
Reckel S, Hantschel O. Reckel S, et al. Among authors: hantschel o. Oncotarget. 2017 Sep 14;8(45):78257-78258. doi: 10.18632/oncotarget.20874. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108223 Free PMC article. No abstract available.
Kinase-templated abiotic reaction.
Saarbach J, Lindberg E, Folliet S, Georgeon S, Hantschel O, Winssinger N. Saarbach J, et al. Among authors: hantschel o. Chem Sci. 2017 Jul 1;8(7):5119-5125. doi: 10.1039/c7sc01416c. Epub 2017 May 24. Chem Sci. 2017. PMID: 28970898 Free PMC article.
The druggability of SH2 domains unmasked.
Hantschel O. Hantschel O. Nat Chem Biol. 2024 Mar;20(3):271-272. doi: 10.1038/s41589-024-01557-w. Nat Chem Biol. 2024. PMID: 38361089 No abstract available.
Mechanisms of resistance to BCR-ABL and other kinase inhibitors.
Lamontanara AJ, Gencer EB, Kuzyk O, Hantschel O. Lamontanara AJ, et al. Among authors: hantschel o. Biochim Biophys Acta. 2013 Jul;1834(7):1449-59. doi: 10.1016/j.bbapap.2012.12.009. Epub 2012 Dec 28. Biochim Biophys Acta. 2013. PMID: 23277196 Review.
CDK6 degradation hits Ph+ ALL hard.
Hantschel O. Hantschel O. Blood. 2020 Apr 30;135(18):1512-1514. doi: 10.1182/blood.2020005136. Blood. 2020. PMID: 32353124 Free article. No abstract available.
Chronic myeloid leukemia--some topical issues.
Mughal T, Cortes J, Cross NC, Donato N, Hantschel O, Jabbour E, Kantarjian H, Melo JV, Skorski T, Silver RT, Goldman JM. Mughal T, et al. Among authors: hantschel o. Leukemia. 2007 Jul;21(7):1347-52. doi: 10.1038/sj.leu.2404733. Epub 2007 May 10. Leukemia. 2007. PMID: 17495971 Review. No abstract available.
Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open Questions.
Valent P, Orfao A, Kubicek S, Staber P, Haferlach T, Deininger M, Kollmann K, Lion T, Virgolini I, Winter G, Hantschel O, Kenner L, Zuber J, Grebien F, Moriggl R, Hoermann G, Hermine O, Andreeff M, Bock C, Mughal T, Constantinescu SN, Kralovics R, Sexl V, Skoda R, Superti-Furga G, Jäger U. Valent P, et al. Among authors: hantschel o. Hemasphere. 2021 Feb 17;5(3):e536. doi: 10.1097/HS9.0000000000000536. eCollection 2021 Mar. Hemasphere. 2021. PMID: 33623882 Free PMC article. Review.
77 results